Online Store

This session presents results from a CDC project focused on expanding access to and tailoring the program to effectively reach communities.

Sponsored by Dexcom, this webinar explores the powerful features and benefits of the personal and professional Dexcom G6 CGM systems that support individualized treatment plans in diabetes management.

This online course focuses on diabetes-related cardiometabolic co-conditions: depression and anxiety, liver disease, diabetes-related neuropathies, overweight and obesity, and cardiovascular and renal co-conditions. Learn how to assess diabetes-related co-conditions and the treatment options that are available for each co-condition.

Sponsored by Dexcom, learn more about the glycemic benefits of incorporating a Dexcom CGM System during key times for people with diabetes.

This program will provide an update on currently available technology and its role in patient care as well as a look into what is expected to be FDA approved in the next 6-12 months.

The program will overview how the MedStar Diabetes Boot Camp team partnered with primary care physicians and endocrinologists to implement a comprehensive DSMES and Medication Management Program to overcome therapeutic inertia.

This presentation will highlight that the value of the DCES can be monetized in the device training process and will help attendees understand billing codes to use, when and how to use them. Having this knowledge increases the value of the DCES in primary care, endocrinology and private practice models.

Sponsored by Provention Bio.

This session will review the use of blood glucose monitors, continuous glucose sensors and the role of the DCES in open-ended discussions around improving TIR.

Review the unique health beliefs that can influence people from different cultural backgrounds when providing diabetes prevention education

This session will focus on strategies and tools that inpatient DCESs can use to support both patients and interdisciplinary teams.

Learn about new resources designed to allow lifestyle coaches, and their mentors, to assess key competencies, enhance coaching quality, and identify opportunities for continuous improvement in the diabetes prevention program.

This interactive symposium, with charismatic expert clinicians presenting information in a conversational style on the Med Table Talk™ platform, will focus on overcoming clinical inertia, weight loss as a treatment target, why it is important to understand the newest data on the role and effects of incretins, and shared decision making for sustained weight loss and glucose management. 

Learn about key features and functionality unique to the Omnipod DASH^® Insulin Management System, designed to simplify diabetes management.

In this session, we will examine the growth of technology, available and emerging apps and the benefits of leveraging technology to promote equitable care for people with diabetes.

Learn about the FreeStyle Libre 3 system, the smallest and thinnest sensor available that provides minute-to-minute glucose readings that stream directly to the users' compatible smartphone.

This session will review current evidence-based recommendations for the management of peripheral neuropathy

Sponsored by CeQur, you will learn about a new bolus-only insulin patch that can be worn for up to 3 days and can be trained in about 15 minutes.

This course that focuses on essential knowledge of diabetes needed by health care team professionals who interact with people with diabetes and related conditions but whose primary focus is not diabetes.

This webinar will focus on how diabetes care and education specialists can help people with diabetes in selecting eating approaches that fit their needs.

This session will provide a review of current management recommendations for people with type 2 diabetes and CKD and utilize a case scenario to highlight the role of the DCES in optimizing CKD outcomes.

This session will review the current insulin products available, dosing and titration protocols, monitoring parameters, and medication education. Additionally, pipeline insulin products and current therapy trends will be discussed.

This presentation will review the staging of T1D, the relationship between early autoantibody detection and DKA prevention, and current research aimed at preventing or delaying T1D onset.

This session will review the mechanism of action for SGLT2i to improve renal outcomes and summarize clinical evidence supporting SGLT2i in people with CKD with or without diabetes. 

Gain a deeper understanding of the Dexcom G6 Real-Time Continuous Glucose Monitoring (RT-CGM) System and the power of data analysis with Dexcom Clarity software by implementing the ICC framework to simplify clinician workflow and improve diabetes management. Sponsored by Dexcom.